Palisade Bio (PALI) Net Margin Growth (1y) (2012 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -8.48 Mn |
| Sep 30, 2020 | 1.07 Mn |
| Jun 30, 2020 | -4.99 Mn |
| Mar 31, 2020 | 6.43 Mn |
| Dec 31, 2019 | -1.36 Mn |
| Sep 30, 2019 | -177,204.00 |
| Jun 30, 2019 | -2.34 Mn |
| Mar 31, 2019 | -385,664.00 |
| Dec 31, 2018 | -7.05 Mn |
| Sep 30, 2018 | 2.02 Mn |
| Jun 30, 2018 | 16.80 Mn |
| Mar 31, 2018 | 8.07 Mn |
| Dec 31, 2017 | 6.57 Mn |
| Sep 30, 2017 | 10.28 Mn |
| Jun 30, 2017 | -306,812.00 |
| Mar 31, 2017 | 9.04 Mn |
| Dec 31, 2016 | 12.44 Mn |
| Sep 30, 2016 | 1.99 Mn |
| Jun 30, 2016 | 5.18 Mn |
| Mar 31, 2016 | -9.11 Mn |
| Dec 31, 2015 | -8.26 Mn |
| Sep 30, 2015 | -13.64 Mn |
| Jun 30, 2015 | -13.97 Mn |
| Mar 31, 2015 | -3.92 Mn |
| Dec 31, 2014 | 1.95 Mn |
| Sep 30, 2014 | 7.35 Mn |
| Jun 30, 2014 | 6.85 Mn |
| Mar 31, 2014 | -13.12 Mn |
| Dec 31, 2013 | -1.93 Mn |
| Sep 30, 2013 | -16.11 Mn |
| Jun 30, 2013 | -14.33 Mn |
| Mar 31, 2013 | -128,722.00 |
| Dec 31, 2012 | -10.77 Mn |
| Sep 30, 2012 | 159,636.00 |